T1/ST2 (IL-33 R) Mouse, Monoclonal Antibody, PE Conjugated, 0.1 mL

Mouse T1/ST2 (IL-33 R) PE conjugated monoclonal antibody (Clone DJ8, Host / Isotype Subclass: Rat IgG1, light chain not isotyped) for the identification and purification of murine T helper 2 (Th2)...

Antibodies

101001PE

To request a quote or place an order: Click here

For research use only. Not for use in diagnostic procedures.

Mouse T1/ST2 (IL-33 R) PE conjugated monoclonal antibody (Clone DJ8, Host / Isotype Subclass: Rat IgG1, light chain not isotyped) for the identification and purification of murine T helper 2 (Th2) cells and all forms of murine mast cells.

T1/ST2 (also known as IL-1 R4 or IL-33Ra) is a transmembrane glycoprotein expressed on mast cells and Th2 cells. It is a selective marker for murine Th2 lymphocytes and plays a role in regulating inflammatory responses. IL-33 is a recently identified member of the IL-1 family of cytokines and is involved in Th2 mediated immune responses. IL-33 mediates its biological effects via T1/ST2 binding. The roles of IL-33 and T1/ST2 (IL-33Ra) have been investigated in many immune responses such as allergy, asthma, rheumatoid arthritis and osteoarthritis.

    References/Citations:

    Yan, C., Kuang, W., Ma, G., Guo, F., Jin, L., Wan, H., ... & Wang, L. (2025). E3 ligase RNF128 restricts A. alternata-induced ILC2 activation and type 2 immune response in the murine lung. Scientific Reports, 15(1), 1193.

    Gurram, R. K., Wei, D., Yu, Q., Butcher, M. J., Chen, X., Cui, K., ... & Zhu, J. (2023). Crosstalk between ILC2s and Th2 cells varies among mouse models. Cell Reports, 42(2).

    Sasse, C., Barinberg, D., Obermeyer, S., Debus, A., Schleicher, U., & Bogdan, C. (2022). Eosinophils, but not type 2 innate lymphoid cells, are the predominant source of interleukin 4 during the innate phase of Leishmania major infection. Pathogens, 11(8), 828.

    Lai, D., Chen, W., Zhang, K., Scott, M. J., Li, Y., Billiar, T. R., ... & Fan, J. (2022). GRK2 regulates group 2 innate lymphoid cell mobilization in sepsis. Molecular Medicine, 28(1), 1-12.

    Cautivo, K. M., Matatia, P. R., Lizama, C. O., Mroz, N. M., Dahlgren, M. W., Yu, X., ... & Molofsky, A. B. (2022). Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation. Immunity55(2), 254-271.

    Huang, Y., Li, X., Zhu, L., Huang, C., Chen, W., Ling, Z., ... & Zhang, Y. (2022). Thrombin cleaves IL‐33 and modulates IL‐33‐activated allergic lung inflammation. Allergy.

    Frech, M., Omata, Y., Schmalzl, A., Wirtz, S., Taher, L., Schett, G., ... & Sarter, K. (2022). Btn2a2 Regulates ILC2–T Cell Cross Talk in Type 2 Immune Responses. Frontiers in immunology13.

    O’Leary, C. E., Sbierski-Kind, J., Kotas, M. E., Wagner, J. C., Liang, H. E., Schroeder, A. W., ... & Locksley, R. M. (2022). Bile acid–sensitive tuft cells regulate biliary neutrophil influx. Science Immunology, 7(69), eabj1080.

    Steele, H., Sachen, K., McKnight, A. J., Soloff, R., & Herro, R. (2021). Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders. Frontiers in immunology, 12, 692127.

    Arora, P., Andersen, D., Moll, J. M., Danneskiold-Samsøe, N. B., Xu, L., Zhou, B., ... & Brix, S. (2021). Small Intestinal Tuft Cell Activity Associates With Energy Metabolism in Diet-Induced Obesity. Frontiers in Immunology12.

    Van der Jeught, K., Sun, Y., Fang, Y., Zhou, Z., Jiang, H., Yu, T., ... & Eyvani, H. (2020). ST2 as checkpoint target for colorectal cancer immunotherapy. JCI insight, 5(9).

    Symowski, C., & Voehringer, D. (2019). Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. European Journal of Immunology.

    Kobayashi, T., Voisin, B., Kennedy, E. A., Jo, J. H., Shih, H. Y., Truong, A., ... & Moro, K. (2019). Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell, 176(5), 982-997

    Moldaver, D. M., Bharhani, M. S., Rudulier, C. D., Wattie, J., Inman, M. D., & Larché, M. (2019). Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy. Journal of Allergy and Clinical Immunology, 143(3), 1087-1099.

    Lai, D., Tang, J., Chen, L., Fan, E. K., Scott, M. J., Li, Y., ... & Fan, J. (2018). Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis. Cell death & disease, 9(3), 369.

    Schneider, C., O’Leary, C. E., von Moltke, J., Liang, H. E., Ang, Q. Y., Turnbaugh, P. J., ... & Locksley, R. M. (2018). A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell.

    Omata, Y., Frech, M., Primbs, T., Lucas, S., Andreev, D., Scholtysek, C., ... & Andreas, N. (2018). Group 2 Innate Lymphoid Cells Attenuate Inflammatory Arthritis and Protect from Bone Destruction in Mice. Cell reports, 24(1), 169-180.

    Cutting Edge: Atopy Promotes Th2 Responses to Alloantigens and Increases the Incidence and Tempo of Corneal Allograft Rejection
    Clay Beauregard et al., J. Immunol., Jun 2005; 174: 6577 - 6581.

    Predominance of Th2 response in human abdominal aortic aneurysm: Mistaken identity for IL-4-producing NK and NKT cells? Chan WL, et al. Cellular Immun (2005) 233:109-114

    Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells Borzychowski, A.M. et al., Eur J Immunol (2005) 35:3054-3063.

    Atherosclerotic Abdominal Aortic Aneurysm and the Interaction Between Autologous Human Plaque-Derived Vascular Smooth Muscle Cells, Type-1 NKT, and Helper T-Cells Chan, W.L. et al., Circ Res (2005) 96:675-683

    NKT cell subsets in infection and inflammation Chan WL, et al. Immun Lett (2003) 85:159-163Regulation of ST2L expression on T helper (Th) type 2 cells Carter, R.W. et al., Eur. J. Immunol. (2001) 31:2979-2985

    Human IL-18 Receptor and ST@L Are Stable and Selective markers for the Respective Type 1 and Type 2 Circulating Lymphocytes Chan WL, et al. J Immunol. 2001 Aug 1; 167(3):1238-44.